Comparison of therapeutic evaluation between WHO criteria and RECIST for advanced breast cancer
Ling Leng(Tianjin University of Traditional Chinese Medicine), Zhong Sheng Tong(Breast Cancer Care)
Zhonghua zhongliu fangzhi zazhi
November 1, 2008
Cited by 0
Related Papers
Outcome over seven years of healthy adults with and without subjective cognitive impairment
|Alzheimer s & Dementia|2010|582
Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples
|Signal Transduction and Targeted Therapy|2020|184
MoGCN: A Multi-Omics Integration Method Based on Graph Convolutional Network for Cancer Subtype Analysis
|Frontiers in Genetics|2022|159
MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2– advanced breast cancer: the multinational randomized phase III study
|Therapeutic Advances in Medical Oncology|2020|110
Polychlorinated biphenyls and breast cancer: A congener-specific meta-analysis
|Environment International|2015|85